Abstract
Changes in the serotonergic nervous system after the intracerebroventricular (i.c.v.) administration of ethylcholine aziridinium (AF64A, 3 nmol/each ventricle) were studied in rats. Two weeks after the infusion of AF64A, the levels of 5-HT and 5-HIAA in microdialysed cerebrospinal fluid (CSF), the levels of total 5-HT and 5-HIAA, the density of serotonin uptake sites and the activities of tryptophan hydroxylase (TPH) and monoamine oxidase (MAO) in various brain regions were determined. After AF64A administration, the concentrations of 5-HT in lateral ventricle were increased and the levels of 5-HIAA were decreased. However, the hippocampal levels of total 5-HT were decreased without changes in the levels of 5-HIAA and the hippocampal turnover rates of 5-HT increased. Also, the density of uptake sites of serotonin ([3H]citalopram binding sites) was decreased in the various brain. The activities of TPH were increased in striatum and frontal cortex and the activity of MAO was also increased in striatum. These results indicate that AF64A induces an increase in serotonergic neuronal activity and decreased densities of 5-HT uptake sites which may affect the change in the other parameters of serotonergic neuronal activities. Furthermore, these results suggest that the impaired cholinergic neuronal activity induces the alteration in the serotonergic nervous activities.
Similar content being viewed by others
References
Abe, E., Murai, S., Saito, H., Masuda, Y., Takasu, Y., Shiotani, T., Tachizawa, H., and Itoh, T., Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice. J. Neural. Transm., 95, 179–193 (1994).
Baik, S. Y., Jung, K. H., Choi, M. R., Yang, B. H., Kim, S. H., Lee, J. S., Oh, D. Y., Choi, I. G., Chung, H., and Chai, Y. G., Fluxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neurosci. Lett., 374, 53–57 (2005).
Bessho, T., Takashina, K., Eguchi, J., Komatsu, T., and Saito, K., MKC-231, a choline-uptake enhancer:(1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats. J. Neural. Transm., 115, 1019–1025 (2008).
Cassel, J. C. and Jeltsch, H., Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience, 69, 1–41 (1995).
Cassidy, F., Orlek, B. S., and Hadley, M. S., Chemical approaches to the enhancement of cholinergic function for the treatment of senile dementia. In: Nicholson, D., (Ed.) Anti-dementia agents: Research and prospects for therapy. Academic press, London, pp. 33–83, (1994).
Chen, C. P., Alder, J. T., Bowen, D. M., Esiri, M. M., McDonald, B., Hope, T., Joset, K.A., and Francis, P. T., Presynaptic serotonergic markers in community acquired cases of Alzheimer’s disease: correlations with depression and neuroleptic medication. J. Neurochem., 66, 1592–1598 (1996).
Chrobak, J. J., Hanin, I., Schmechel, D. E., and Walsh, T. J., AF64A induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res., 463, 107–117 (1988).
Consolo, S., Arnaboldi, S., Ranponi, S., Nannini, L., Ladinsky, H., and Baldi, G., Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT1B receptors. J. Pharmacol. Exp. Ther., 277, 823–830 (1996).
Cooper, J. R., Bloom, F. E., and Rath, R. H., The biological basis of neuropharmacology. Oxford University Press, New York (2003).
Crespi, D., Gobbi, M., and Mennini, T., 5-HT3 serotonin hetero-receptors inhibit [3H] acetylcholine release in rat cortical synaptosomes. Pharmacol. Res., 35, 351–354 (1997).
Fink, K. B. and Gothert, M., 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev., 59, 360–417 (2007).
Fisher, A., Mantione, C. R., Abraham, D. J., and Hanin, I., Lone term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo. J. Pharmacol. Exp. Ther., 222, 140–145 (1982).
Francis, P. T., Pangalos, N. M., Stephens, P. H., Bartlett, J. R., Bridges, P. K., Malizia, A. L., Neary, D., Procter, A. W., Thomas, D. J., and Bowen, D. M., Antemortem measurements of neurotransmitter: possible implications for pharmacotherapy of Alzheimer’s disease and depression. J. Neurol. Neurosurg. Psychiatry, 56, 80–84 (1993).
Glowinski, J. and Iversen, L. L., Regional studies of catecholamine in the rat brain-I. the disposition of 3H-norepinephrine, 3H-dopamine and 3H-DOPA in various regions of the rat. J. Neurochem., 13, 655–669 (1966).
Gower, A. J., Rousseau, D., Jamsin, P., Gobert, J., Hanin, I., and Wulfert, E., Behavioral and histological effects of low concentrations of intraventricular AF64A. Eur. J. Pharmacol., 166, 271–281 (1989).
Grecksch, G., Zhou, D., Franke, C., Schroder, U., Sabel, B., Becker, A., and Huether, G., Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br. J. Pharmacol., 122, 1725–1731 (1997).
Hanin, I., Mantione, C. R., and Fisher, A., AF64A induced neurotoxicity: a potential animal model in Alzheimer’s disease. In: Corkin, S., Davis, K. L., Growdon, L. H., Usdin, E., Wurtman, R. J., (Eds.) Alzheimer’s Disease: A report of progress (Aging). Raven, New York, pp. 267–270, (1992).
Hortnagl, H., Potter. P. E., and Hanin, I., Effects of cholinergic deficit induced by ethylcholine aziridinium on serotonergic parameters in rat brain. Neuroscience, 22, 203–213 (1987).
Jellinger, K. A., Morphological substrates of dementia in parkinsonism. A critical update, J. Neural Transm. Suppl., 51, 57–82 (1997).
Johnson, M., Elayan, I., Hanson, G. R., Foltz, R. L., Gibb, J. W., and Lim, H. K., Effects of 3, 4-dihydroxymethamphetamine and 2,4,5-trihydrosymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J. Pharmacol. Exp. Ther., 261, 447–453 (1992).
Labert, F., Pasquier, F., and Petit, H., Behavior effects of trazodone in Alzheimer’s disease. J. Clin. Psychiatry, 55, 536–538 (1994).
Larson, E. B., Kukuller, W. A., and Katzman, R. L., Cognitive impairment: dementia and Alzheimer’s disease. Annu. Rev. Public Health, 13, 431–449 (1992).
Lehmann, O., Jeltsch, H., Lehnardt, O., Pain, L., Lazarus, C., and Cassel, J. C., Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgGsaporin and 5,7-hydroxytryptamine: neurochemical and behavioural characterization. Eur. J. Neurosci., 12, 67–79 (2000).
Lim, D. K., Ma, Y., and Yi, E. Y., Effects of intracerebroventricular administration of ethylcholine aziridinium (AF64A) on dopaminergic nervous systems. Arch. Pharm. Res., 19, 23–29 (1996).
Lim, D. K., Oh, Y. H., Kim, H. S., Impairments of learning and memory following intracerebroventricular administration of AF64A in rats. Arch. Pharm. Res., 24, 234–239 (2001).
Lowry, O. H., Rosebrough, N. R., Farr, A. L., and Tandall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265–275 (1951).
Ma, Y. and Lim, D. K., Effects of i.c.v. administration of ethylcholine aziridinium (AF64A) on the central glutamatergic nervous systems in rats. Arch. Pharm. Res., 20, 39–45 (1997).
Madjid, N., Tottie, E. E., Luttgen, M., Meister, B., Sandin, J., Kuzmin, A., 5-hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: Interactions with cholinergic and glutaminergic mechanisms. J. Pharmacol. Exp. Ther., 316, 581–591 (2006).
Mantione, C. R., Zigmond, M. J., Fisher, A., and Hanin, I., Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats. J. Neurochem., 41, 251–255 (1983).
Mash, D. C., Flynn, D. D., and Potter L. T., Loss if M2 muscarinic receptors in the cerebral cortex in Alzheimer’s disease and experimental cholinergic denervation. Science, 228, 1115–1117 (1985).
Meana, J. J., Johansson, B., Herrera-Marschitz, M., O’Conner, W. T., Goiny, M., and Parkinson, F. E., Fredholm, B.B., and Ungerstedt, U., Effect of the neurotoxin AF64A on intrinsic and extrinsic neuronal systems of rat neostriatum measured by in vivo microdialysis. Brain Res., 596, 65–72 (1992).
Opello, K. D., Stackman, R. W., Ackerman, S., and Walsh, T. J., AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: Relation to cholinergic hypofunction. Physiol. Behav., 54, 1227–1233 (1983).
Osman, M. Y. and Osman, H. M., Inhibitory effect of acetylcholine on monoamine oxidase A and B activity in different parts of rat brain. Arzneimittelforschung, 58, 493–496 (2008).
Owens, M. J. and Nemeroff, C. B., Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem., 40, 288–295 (1994).
Paxinos, G. and Watson, C., The brain in stereotaxic coordinates. Academic Press, New York, (1986).
Pittel, Z., Cohen, S., Fisher, A., and Heldman, E., Differential long -term effect of AF64A on [3H]ACh synthesis and release in rat hippocampal synaptosomes. Brain Res., 586, 148–151 (1992).
Rattray, M., Baldessari, S., Gobbi, M., Mennini, T., Samanin, R., and Bendotti, C., p-Chlorophenylamine changes serotonin transporter mRNA levels and expression of the gene product. J. Neurochem., 67, 463–472 (1996).
Richter-Levin, G. and Segal, M., Age-related cognitive deficits in rats are associated with a combined loss of cholinergic and serotonergic functions. Ann. N.Y. Acad. Sci., 695, 254–257 (1993).
Saito, H., Matsumoto, M., Togashi, H., and Yoshioka, M., Functional interactions between serotonin and other neuronal systems: Focus on in vivo microdialysis studies. Jpn. J. Pharmacol., 70, 203–225 (1996).
Santucci, A. C., Knott, P. J., and Haroutunian, V., Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur. J. Pharmacol., 295, 7–17 (1996).
Severino, M., Pedersen, A. F., Trajkovska, V., Christensen, E., Lohals, R., Veng, L. M., Knudsen, G. M., and Aznar, S., Selective immunolesion of cholinergic neuron lead to longterm changes in 5-HT2A receptor levels in hippocampus and frontal cortex. Neurosci. Lett., 428, 47–51 (2007).
Simpson, K. L., Fisher, T. M., Waterhouse, B. D., and Lin, R. C. S., Projection patterns from the Raphe nuclear comples to the ependymal wall of the ventricular system in the rat. J. Comp. Neurol., 399, 61–72 (1998).
Stenstrom, A., Hardy, J., and Oreland, L., Intra- and extradopamine synaptozomal localization of monoamine oxidase in striatal homogenates form four species. Biochem. Pharmacol., 36, 2931–2935 (1987).
Strolin-Benedetti, M. and Dostert, P., Stereochemical aspects of MAO interactions: reversible and selective inhibitors of mono-amine oxidase. Trends Pharmacol. Sci., 6, 246–251 (1985).
Suzuki, O., Katsumata, Y., and Oya, M., Effects of β-phenylamine concentration on its substrate specificity for type A and type B monoamine oxidase. Biochem. Pharmacol., 28, 953–956 (1979).
Topgi, H., Ueno, M., Abe, T., Takahashi, S., and Nozaki, Y., Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type. J. Neural Transm. Park. Dis. Dement. Sect., 4, 69–77 (1992).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, SH., Lim, D.K. Increases in serotonergic neuronal activity following intracerebroventricular administration of AF64A in rats. Arch. Pharm. Res. 33, 301–308 (2010). https://doi.org/10.1007/s12272-010-0216-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0216-3